| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $81.39M | $33.28M | $14.02M | $15.92M | $37.70M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $187.36M | $197.49M | $151.08M | $132.28M | $110.89M |
| R&D | $129.62M | $119.48M | $103.78M | $85.72M | $67.13M |
| SG&A | $52.90M | $54.22M | $47.29M | $46.55M | $43.77M |
| Operating Income | -$105.97M | -$164.21M | -$137.06M | -$116.36M | -$73.19M |
| Interest Expense | $12.20M | $13.27M | $13.24M | $4.95M | $288.00K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$114.20M | -$147.79M | -$84.03M | -$129.62M | -$79.56M |
| EPS (basic) | -1.4200 | -2.1200 | -1.4900 | -2.8700 | -1.8000 |
| EPS (diluted) | -1.4200 | -2.1200 | -1.4900 | -2.8700 | -1.8000 |
| Shares (diluted) | $80.43M | $69.82M | $56.49M | $45.18M | $44.14M |